https://www.selleckchem.com/products/Honokiol.html
To report trends of intravitreal corticosteroid use and explore the relationship between career experience, reported industry payments, and prescribing habits. Retrospective review of ophthalmologists who administered intravitreal dexamethasone implants (DEX) and triamcinolone acetonide (TA) injections between August 2013 to December 2017. A total of 1070 US ophthalmologists were reimbursed by Medicare for 522,804 DEX injections and 2.6 million TA injections. There was a significant positive trend in the number of DEX (P=.01), but not
Like
Comment
Share
